The company expired its plan on May 23, 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.94 HKD | -2.08% |
|
+1.08% | -35.62% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-35.62% | 122M | |
+6.96% | 101B | |
+8.29% | 42.63B | |
+82.32% | 29.77B | |
-11.82% | 16.14B | |
+1.39% | 14.31B | |
-12.13% | 11.55B | |
+176.65% | 10.53B | |
+6.74% | 9.2B | |
-55.52% | 8.98B |
- Stock Market
- Equities
- 1672 Stock
- News Ascletis Pharma Inc.
- Ascletis Pharma Inc.'s Equity Buyback announced on June 30, 2023, has expired.